ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
124 hedge funds and large institutions have $307M invested in Achillion Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-3
Holders Change %
-2.36%
% of All Funds
2.84%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
14
Increased
45
Reduced
34
Closed
17
Calls
$426K
Puts
$151K
Net Calls
+$275K
Net Calls Change
-$2.59M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.11M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.54M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$720K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$689K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.38M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.08M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.06M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.47M |
| 5 |
AG
Artal Group
Luxembourg
|
-$2.78M |
